Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Diagnostic Pitfalls, Pathophysiology, Clinical Management, and Strategies for Prevention
Euglycemic diabetic ketoacidosis (EDKA) has emerged as a clinically important metabolic emergency in the era of sodium-glucose cotransporter 2 (SGLT2) inhibitors. Characterized by significant ketosis and metabolic acidosis despite absent or only modest…
